Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical developme... Read more
Bristol-Myers Squibb
320 followers
Astellas Pharma
63 followers
Viatris
54 followers
NYU Langone Health
51 followers
Syneos Health
38 followers
Prescient Healthcare Group
29 followers
Parexel
21 followers
PCI Pharma Services
14 followers
Empower Pharmacy
11 followers
Madrigal Pharmaceuticals
10 followers
Curia Global
9 followers
Lantheus
8 followers